Literature DB >> 28481869

The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression.

F Zhang1, H Tang1, Y Jiang1, Z Mao1.   

Abstract

GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1. However, whether and how GATA3 participates in the process of DNA repair, which is often associated with tumorigenesis, has not been investigated. Here we demonstrate that GATA3 is required for the repair of DNA double-strand breaks (DSBs) by homologous recominbation (HR). Mechanistic studies indicate that at both the protein and the mRNA level, depleting GATA3 leads to reduced expression of CtIP, an essential HR factor involved in end resection, thereby suppressing the repair of DSBs by HR and sensitizing cells to etoposide induced DNA DSBs. Further studies indicate that upon the occurrence of DNA DSBs GATA3 directly binds to the CtIP promoter at the region of -2119 to -2130 and -2274 to -2285, and promotes the transcription of CtIP. Overexpression of CtIP in GATA3 depleted cells rescues the decline of HR, and cell survival in the presence of etoposide. In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and CtIP in paratumors, but the correlation turned insignificant in mammary tumors. Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair. In summary, our data delineates the regulatory mechanisms of GATA3 in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and HR to stabilize genomes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28481869     DOI: 10.1038/onc.2017.127

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

Review 1.  The GATA family (vertebrates and invertebrates).

Authors:  Roger K Patient; James D McGhee
Journal:  Curr Opin Genet Dev       Date:  2002-08       Impact factor: 5.578

2.  CtIP, a multivalent adaptor connecting transcriptional regulation, checkpoint control and tumor suppression.

Authors:  Guikai Wu; Wen-Hwa Lee
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

Review 3.  Role of autophagy in cancer prevention.

Authors:  Hsin-Yi Chen; Eileen White
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

4.  Impaired DNA double-strand break repair contributes to the age-associated rise of genomic instability in humans.

Authors:  Z Li; W Zhang; Y Chen; W Guo; J Zhang; H Tang; Z Xu; H Zhang; Y Tao; F Wang; Y Jiang; F L Sun; Z Mao
Journal:  Cell Death Differ       Date:  2016-07-08       Impact factor: 15.828

5.  BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.

Authors:  D Tkocz; N T Crawford; N E Buckley; F B Berry; R D Kennedy; J J Gorski; D P Harkin; P B Mullan
Journal:  Oncogene       Date:  2011-11-28       Impact factor: 9.867

Review 6.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

7.  Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.

Authors:  Jérôme Eeckhoute; Erika Krasnickas Keeton; Mathieu Lupien; Susan A Krum; Jason S Carroll; Myles Brown
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 8.  GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?

Authors:  Motoki Takaku; Sara A Grimm; Paul A Wade
Journal:  Gene Expr       Date:  2015

9.  Human SIRT6 promotes DNA end resection through CtIP deacetylation.

Authors:  Abderrahmane Kaidi; Brian T Weinert; Chunaram Choudhary; Stephen P Jackson
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

10.  Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa.

Authors:  Hanna Haveri; Mia Westerholm-Ormio; Katri Lindfors; Markku Mäki; Erkki Savilahti; Leif C Andersson; Markku Heikinheimo
Journal:  BMC Gastroenterol       Date:  2008-04-11       Impact factor: 3.067

View more
  6 in total

1.  ATM controls the extent of DNA end resection by eliciting sequential posttranslational modifications of CtIP.

Authors:  Jinhua Han; Li Wan; Guixing Jiang; Liping Cao; Feiyu Xia; Tian Tian; Xiaomei Zhu; Mingjie Wu; Michael S Y Huen; Yi Wang; Ting Liu; Jun Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

2.  Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.

Authors:  Victor Trevino
Journal:  Mol Genet Genomic Med       Date:  2019-07-11       Impact factor: 2.183

3.  Integrated stress response control of granulosa cell translation and proliferation during normal ovarian follicle development.

Authors:  Evelyn Llerena Cari; Synneva Hagen-Lillevik; Asma Giornazi; Miriam Post; Anton A Komar; Leslie Appiah; Benjamin Bitler; Alex J Polotsky; Nanette Santoro; Jeffrey Kieft; Kent Lai; Joshua Johnson
Journal:  Mol Hum Reprod       Date:  2021-08-07       Impact factor: 4.025

4.  TopicNet: a framework for measuring transcriptional regulatory network change.

Authors:  Shaoke Lou; Tianxiao Li; Xiangmeng Kong; Jing Zhang; Jason Liu; Donghoon Lee; Mark Gerstein
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

5.  ALC1/eIF4A1-mediated regulation of CtIP mRNA stability controls DNA end resection.

Authors:  Fernando Mejías-Navarro; Guillermo Rodríguez-Real; Javier Ramón; Rosa Camarillo; Pablo Huertas
Journal:  PLoS Genet       Date:  2020-05-11       Impact factor: 5.917

6.  Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3.

Authors:  Farzaneh Darbeheshti; Elham Zokaei; Yaser Mansoori; Sima Emadi Allahyari; Zeeba Kamaliyan; Sepideh Kadkhoda; Javad Tavakkoly Bazzaz; Nima Rezaei; Abbas Shakoori
Journal:  Cancer Cell Int       Date:  2021-06-14       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.